Download PDF
Hamostaseologie 2003; 23(03): 109-112
DOI: 10.1055/s-0037-1619586
Original Article
Schattauer GmbH

Cerebral sinovenous thrombosis during asparaginase treatment

Case 3Zerebrale Sinusvenenthrombose unter Asparaginase-Behandlung
K. Leibundgut
1   Universitäts-Kinderklinik, Pädiatrische Hämatologie/Onkologie, Switzerland
,
A. Hirt
1   Universitäts-Kinderklinik, Pädiatrische Hämatologie/Onkologie, Switzerland
,
C. Zwicky
2   Hämatologisches Zentrallabor, Inselspital, Universität Bern, Switzerland
,
W.A. Wuillemin
3   Kantonsspital, Abteilung Hämatologie, Luzern, Switzerland
› Author Affiliations
Further Information

Publication History

Publication Date:
23 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

A boy (age: 71/12 years) with acute lymphoblastic leukaemia developed thrombosis of the sinus sagitalis superior with secondary haemorrhagic infarction while on induction treatment with vincristine, prednisone, and asparaginase. Based on this report, the potential pathogenic mechanisms are discussed with respect to congenital prothrombotic defects as well as to the role of antileukaemic treatment. Current hypotheses on mechanisms for thromboembolism in children and proposed prophylactic strategies are briefly summarized.

Zusammenfassung

Ein 71/12 Jahre alter Knabe mit akuter lymphatischer Leukämie entwickelte während der Induktionstherapie mit Vincristin, Asparaginase und Prednison eine Thrombose des Sinus sagitalis superior mit sekundärer hämorrhagischer Infarzierung. Anhand dieses Fallbeispiels werden allfällige auslösende Faktoren (z.B. kongenitale prothrombotische Defekte) und die ursächliche Rolle der antileukämischen Therapie besprochen. Die gängigen Hypothesen für die Entstehung einer Thromboembolie beim Kind sowie mögliche präventive Strategien werden kurz zusammengefasst.

Keywords

Thrombosis - acute lymphoblastic leukaemia - asparaginase - child

Schlüsselwörter

Thrombose - akute lymphatische Leukämie - Asparaginase - Kind
 

  • References

  • 1 DeVeber G, Andrew M, Adams C. et al. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345: 417-23.
    CrossrefPubMedSearch in Google Scholar
  • 2 Hill JM, Roberts J, Loeb E. et al. L-asparaginase therapy for leukemia and other malignant neoplasms. JAMA 1967; 202: 882-8.
    CrossrefPubMedSearch in Google Scholar
  • 3 Junker R, Koch HG, Auberger K. et al. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia. Arterioscler Thromb Vasc Biol 1999; 19: 2568-72.
    CrossrefPubMedSearch in Google Scholar
  • 4 Mitchell LG, Sutor AH, Andrew M. Hemostasis in childhood acute lymphoblastic leukemia: coagulopathy induced by disease and treatment. Semin Thromb Hemost 1995; 21: 390-401.
    Thieme ConnectPubMedSearch in Google Scholar
  • 5 Nowak-Göttl U, Junker R, Hartmeier M. et al. Increased lipoprotein(a) is an important risk factor for venous thromboembolism in childhood. Circulation 1999; 100: 743-8.
    CrossrefPubMedSearch in Google Scholar
  • 6 Nowak-Göttl U, Strater R, Heinecke A. et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999; 94: 3678-82.
    CrossrefPubMedSearch in Google Scholar
  • 7 Nowak-Göttl U, Wermes C, Junker R. et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors. Blood 1999; 93: 1595-9.
    PubMedSearch in Google Scholar
  • 8 von Scheven E, Athreya BH, Rose CD. et al. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr 1996; 129: 339-45.
    CrossrefPubMedSearch in Google Scholar
  • 9 Wilimas JA, Hudson M, Rao B. et al. Late vascular occlusion of central lines in pediatric malignancies. Pediatrics 1998; 101: E7.
    PubMedSearch in Google Scholar